Similar articles

• High-dose chemotherapy in nonseminomatous germ cell cancer.

  Kollmannsberger C, Beyer J, Bokemeyer C. Kollmannsberger C, et al. BJU Int. 2009 Nov;104(9 Pt B):1398-403. doi: 10.1111/j.1464-410X.2009.08866.x. BJU Int. 2009. PMID: 19840020 Review. No abstract available.
• A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.

  Stoter G, Sylvester R, Sleijfer DT, ten Bokkel Huinink WW, Kaye SB, Jones WG, van Oosterom AT, Vendrik CP, Spaander P, de Pauw M. Stoter G, et al. Prog Clin Biol Res. 1988;269:381-93. Prog Clin Biol Res. 1988. PMID: 2455909 Clinical Trial. No abstract available.
• Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.

  Ozols RF. Ozols RF. Prog Clin Biol Res. 1988;269:419-27. Prog Clin Biol Res. 1988. PMID: 2455910 Clinical Trial. No abstract available.
• [Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].

  Corti Ortíz D, Fonerón Burgos A, Troncoso Schifferli L. Corti Ortíz D, et al. Actas Urol Esp. 1997 Nov-Dec;21(10):961-3. Actas Urol Esp. 1997. PMID: 9494159 Spanish.
• [Chemotherapy of disseminated germ cell tumors of the testis].

  Tiuliandin SA. Tiuliandin SA. Sov Med. 1987;(11):78-81. Sov Med. 1987. PMID: 2451298 Review. Russian. No abstract available.